Tocagen, Forte Biosciences In Merger
socalTECH
FEBRUARY 20, 2020
As part of the funding, the two said that Alger, BVF Partners LP and OrbiMed have entered into a securities purchase agreement to invest $14 million in the combined company. The newly merged company will operate under the name Forte Biosciences, and trade on the Nasdaq Capital Market as FBRX. READ MORE>>.
113 
Let's personalize your content